Oaktree Capital Management’s SBC Medical Group SBC Stock Holding History

Oaktree Capital Management’s Portfolio SBC Stock Details SBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-250,000	Closed	-$2.68M	–	183
2023 Q4	$2.68M	Hold	250,000	–	–	0.04%	147
2023 Q3	$2.67M	Hold	250,000	–	–	0.04%	162
2023 Q2	$2.57M	Hold	250,000	–	–	0.03%	188
2023 Q1	$2.61M	Hold	250,000	–	–	0.03%	213
2022 Q4	$2.55M	Buy	+250,000	New	+$2.53M	0.03%	236

Other funds holding SBC

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TCM

Tuttle Capital Management Riverside, Connecticut $148M AUM 64.07% 1-Year Est. Return

Oaktree Capital Management's SBC Position: Q1 2024 in Review

Oaktree Capital Management sold out of SBC Medical Group (SBC) in Q1 2024, closing a stake of 250,000 shares — an estimated $2.68M sold.

Oaktree Capital Management first reported a position in SBC in Q4 2022 and held it in 5 quarters. The position peaked at $2.68M in Q4 2023. 5 funds tracked by Wall St. Rank hold SBC as of Q1 2024.

Oaktree Capital Management reported no remaining SBC Medical Group position as of Q1 2024 after selling out during the quarter.
Oaktree Capital Management sold 250,000 SBC Medical Group shares in Q1 2024, an estimated $2.68M.
Oaktree Capital Management first reported a position in SBC Medical Group in Q4 2022 and held it in 5 quarters.
Oaktree Capital Management's SBC Medical Group position peaked at $2.68M in Q4 2023.
5 funds tracked by Wall St. Rank held SBC Medical Group as of Q1 2024.

Based on Oaktree Capital Management's 13F filing for Q1 2024, filed 14 May 2024.